highperformr logo

Arrowhead Pharmaceuticals's Overview

Total employees557
HeadquartersPasadena
Founded

Arrowhead Pharmaceuticals (NASDAQ: ARWR) is a biopharmaceutical company dedicated to developing innovative medicines that treat intractable diseases by silencing the genes that cause them. Utilizing its proprietary Targeted RNAi Molecule (TRiM™) platform, Arrowhead aims to trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. Their diverse pipeline focuses on a range of diseases, including those affecting the liver, lungs, and muscle, with several candidates in various stages of clinical development. The company actively pursues collaborations with other leading pharmaceutical companies to expand the reach and application of its technology.

Where is Arrowhead Pharmaceuticals's Headquarters?

HQ Function

The Pasadena headquarters serves as the central hub for executive leadership, corporate strategy, investor relations, business development, and oversight of global research and clinical operations.

Notable Features:

Located in a modern office building in the heart of Pasadena, offering convenient access to local amenities and a professional environment. The facilities are designed to support corporate functions and foster collaboration.

Work Culture:

The work culture at Arrowhead's headquarters is likely dynamic and science-driven, reflecting its focus on cutting-edge biotechnology. It emphasizes innovation, collaboration among teams, and a strong commitment to addressing unmet medical needs.

HQ Significance:

This location is pivotal for Arrowhead's strategic decision-making and global coordination of its drug development programs. Its presence in Southern California provides access to a rich talent pool and a vibrant biotech ecosystem.

Values Reflected in HQ: The choice of a modern, well-connected location underscores Arrowhead's commitment to professionalism, efficiency, and attracting top-tier talent to drive its mission forward.

Location:

While Arrowhead Pharmaceuticals' primary research, development, and corporate operations are centered in the United States (Pasadena, CA; Madison, WI; Verona, WI), its impact is global. The company conducts clinical trials in numerous countries across North America, Europe, Asia-Pacific, and other regions to evaluate its therapeutic candidates. Furthermore, Arrowhead engages in strategic licensing and collaboration agreements with international pharmaceutical partners, such as GSK, Amgen, Johnson & Johnson (Janssen), and Takeda, to develop and commercialize its RNAi therapies worldwide, extending the reach of its innovative TRiM™ platform.

Street Address:

177 E. Colorado Blvd., Suite 700

City:

Pasadena

State/Province:

CA

Country:

USA

Arrowhead Pharmaceuticals's Global Presence

Madison, Wisconsin/USA

Address: 465 Science Dr, Madison, WI 53711, USA

Leverages Madison's strong biotech ecosystem and proximity to the University of Wisconsin-Madison, fostering scientific innovation and talent acquisition for R&D activities.

Verona, Wisconsin/USA

Address: 1255 Deming Way, Verona, WI 53593, USA

Provides critical in-house manufacturing capacity, ensuring quality control and supply chain management for Arrowhead's investigational medicines.

Buying Intent Signals for Arrowhead Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Arrowhead Pharmaceuticals

As of April 2025, Arrowhead Pharmaceuticals' leadership includes:

Christopher Anzalone, Ph.D. - President and Chief Executive Officer
Javier San Martin, M.D. - Chief Medical Officer
Ken Myszkowski - Chief Financial Officer
Patrick O'Brien, J.D., Ph.D. - Chief Operating Officer and General Counsel
James Hassard - Chief Commercial Officer
Tracie Oliver, Ph.D. - Chief Human Resources Officer
James C. Hamilton, M.D., MBA - Senior Vice President, Clinical Development

Investors of Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals has been backed by several prominent investors over the years, including:

BlackRock, Inc.
Vanguard Group, Inc.
State Street Corporation
Artal Group S.A.
Geode Capital Management, LLC
Deep Track Capital, LP
RA Capital Management

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Over the past year, Arrowhead Pharmaceuticals has focused on strengthening its executive leadership, particularly in commercial and human resources, to support its transition towards potential product commercialization and continued growth. No major executive departures have been publicly announced.

New Appointments:

James Hassard, James Hassard was appointed Chief Commercial Officer to build and lead the company's global commercial strategy and operations.
Tracie Oliver, Ph.D., Tracie Oliver joined as Chief Human Resources Officer, focusing on talent management and organizational development to support Arrowhead's expansion.

Technology (Tech Stack) used by Arrowhead Pharmaceuticals

Discover the tools Arrowhead Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Arrowhead Pharmaceuticals Email Formats and Examples

Arrowhead Pharmaceuticals commonly utilizes the email format combining the first initial of an employee's name with their full last name, followed by '@arrowheadpharma.com'. Variations may exist, but this is a frequently observed pattern for professional communications.

[first_initial][last]@arrowheadpharma.com

Format

jdoe@arrowheadpharma.com

Example

80%

Success rate

News and media

Arrowhead Pharma Official WebsiteMay 21, 2024

Arrowhead Pharmaceuticals Presents Positive Interim Phase 2 Data on Plozasiran for Severe Hypertriglyceridemia at NLA Scientific Sessions 2024

Arrowhead Pharmaceuticals announced positive interim results from the SHASTA-2 Phase 2 clinical study of plozasiran (ARO-APOC3), an investigational RNAi therapeutic for severe hypertriglyceridemia (SHTG). The data, presented at the National Lipid Association (NLA) Scientific Sessions 2024, showed significant reductions in triglycerides and other atherogenic lipoproteins....more

Arrowhead Pharma Official WebsiteMay 9, 2024

Arrowhead Reports Fiscal 2024 Second Quarter Results

Arrowhead Pharmaceuticals reported its financial results for the fiscal second quarter ended March 31, 2024. The company highlighted progress across its pipeline of RNAi therapeutics, including advancements in clinical trials and ongoing strategic collaborations....more

GlobeNewswireFebruary 6, 2024

Arrowhead Pharmaceuticals Enters Agreement with GSK for Exclusive License to ARO-HSD, Now GSK4532378

Arrowhead Pharmaceuticals announced an exclusive license agreement with GSK for ARO-HSD (now GSK4532378), its investigational RNAi therapeutic for alcohol-related and nonalcohol-related liver diseases. Arrowhead received an upfront payment and is eligible for development, regulatory, and commercial milestones, plus royalties....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Arrowhead Pharmaceuticals, are just a search away.